Supernus Pharmaceuticals Inc (NASDAQ:SUPN)

During the Trading Day
17.30 +0.55 / +3.28%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
17.40 +0.10 / +0.58%
Volume: 14.0K

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year




Operating ActivitiesNet Income / Starting Line53.8M-46.3M-92.3M19.9M
Total Other Cash Flow-91.1M983.0K28.3M4.4M
Funds From Operations-36.4M-44.0M-63.2M25.2M
Funds From/For Other Operating Expenses-188.0K3.2M-5.2M17.5M
Net Cash Flow - Operating Activities-36.2M-47.2M-57.9M7.7M
InvestingIncrease In Investments-17.9M-97.7M-85.6M-53.3M
Decrease In Investments26.9M49.5M75.8M53.5M
Capital Expenditures-685.0K-753.0K-1.6M-593.0K
Other Investing - Sources25.6M0.000.00--
Net Cash Flow Investing33.9M-49.0M-12.1M-4.9M
FinancingShort Term Borrowings0.
Long Term Borrowings29.0M-6.0M86.4M0.00
Long Term Debt Reduction0.00-6.8M-24.3M0.00
Net Proceeds Stock Sale29.0K100.7M2.4M571.0K
Common Preferred Redeemed0.
Common Dividends0.
Cash Dividends Paid - Total0.
Other Sources - Financing0.
Other Uses - Financing2.0M0.001.7M1.0K
Net Cash Flow - Financing27.1M87.9M62.7M570.0K
Exchange RateEffect of Exchange Rate on Cash----------
Net Change In Cash24.8M-8.2M-7.3M3.4M

To view my watchlist

Not a member yet?

Sign up now for a free account